Unrelated-donor umbilical cord blood is a useful alternative hematopoietic stem cell source
for patients without suitably matched and readily available related or unrelated stem cell …

As a result of recent media coverage of cord blood transplantation, expectant parents
increasingly ask perinatal caregivers about the possibility of collecting and saving their …

Background Umbilical cord blood is a potential vast source of primitive hematopoietic stem
and progenitor cells available for clinical application to reconstitute the hematopoietic …

Umbilical cord blood is an alternative hematopoietic stem cell source for patients with
hematologic diseases who can be cured by allogeneic hematopoietic cell transplantation …

Human umbilical cord blood has proven to be a feasible alternative source of hematopoietic
stem cells for pediatric and some adult patients with major hematologic disorders. This has …

Since the first report of a successful umbilical cord blood transplantation in 1988, there has
been great interest in the use of cord blood as an alternative stem cell source to treat cancer …

Since the first human cord blood transplant, performed in 1988, cord blood banks have been
established worldwide for collection and cryopreservation of cord blood for allogeneic …

Twenty years has passed since the first report of a successful cord blood transplant was
reported in 1989 in a child with Fanconi's anemia. During these 20 years, the cord blood …

To date, hematopoietic stem and progenitor cells from human umbilical cord blood (CB)
have been employed in approximately 90 allogeneic (56 sibling and 34 unrelated) matched …

Umbilical cord blood has rapidly become a valuable alternative stem cell source for
allogeneic haematopoietic stem cell transplantation. Extensive research over the last 20 …